Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain

Neuroscience Letters

Volumn 417, Issue 1, 2007, Pages 50-54

  Cheng, Xiangying ^a   McAsey, Mary Ellen ^a   Li, Miao ^a   Randall, Shari ^a   Cady, Craig ^b   Nathan, Britto P ^c   Struble, Robert G ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRADLEY UNIVERSITY   (United States)

^c EASTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

ApoE; Brain; Estrogen; Hormone replacement; Hormone therapy; LDL r; LRP; Mouse

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHRONIC DISEASE; CONTROLLED STUDY; DEMENTIA; FEMALE; HIPPOCAMPUS; HORMONAL THERAPY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OLFACTORY BULB; OVARIECTOMY; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; BRAIN; DOWN-REGULATION; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; LDL-RECEPTOR RELATED PROTEIN 1; MICE; MICE, INBRED C57BL; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OLFACTORY BULB; RECEPTORS, LDL; UP-REGULATION;

EID: 34047095238     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.030     Document Type: Article

References (50)

1. Adams M.M., Oung T., Morrison J.H., and Gore A.C. Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-d-aspartate receptor mRNA levels in the hippocampus of female rats. Exp. Neurol. 170 (2001) 345-356
2. Arelin K., Kinashita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland D.K., and Hyman B.T. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Mol. Brain Res. 104 (2002) 38-46
3. Brenner D.E., Kukull W.A., Stergachis A., van Belle G., Bowen J.D., McCormick W.C., Teri L., and Larson E.B. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol. 140 (1994) 262-267
4. Bu G., Williams S., Strickland D.K., and Schwartz A.L. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 89 (1992) 7427-7431
5. Burkhardt M.S., Foster J.K., Laws S.M., Baker L.D., Craft S., Gandy S.E., Stuckey B.G., Clarnette R., Nolan D., Hewson-Bower B., and Martins R.N. Oestrogen replacement therapy may improve memory functioning in the absence of APOE e4. J. Alzheimer's Dis. 6 (2004) 221-228
6. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., Lawler J., Mosher D.F., Bornstein P., and Barres B.A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120 (2005) 421-433
7. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., and Hays J. Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 3005-3007
8. Fagan A.M., Bu G., Sun Y., Daugherty A., and Holtzman D.M. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271 (1996) 30121-30125
9. Fazekas F., Strasser-Fuchs S., Kollegger H., Berger T., Kristoferitsch W., Schmidt H., Enzinger C., Schiefermeier M., Schwarz C., Kornek B., Reindl M., Huber K., Grass R., Wimmer G., Vass K., Pfeiffer K.H., Hartung H.P., and Schmidt R. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57 (2001) 853-857
10. Friedman G., Froom P., Sazbon L., Grinblatt I., Shochina M., Tsenter J., Babaey S., Yehuda B., and Groswasser Z. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52 (1999) 244-248
11. Gibbs R.B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 757 (1997) 10-16
12. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging 21 (2000) 107-116
13. Gibbs R.B., and Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J. Neurosci. Res. 74 (2003) 637-643
14. Gonias S.L., Wu L., and Salicioni A.M. Low-density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91 (2004) 1056-1064
15. Gopalraj R.K., Zhu H., Kelly J.F., Mendiondo M., Pulliam J.F., Bennett D.A., and Estus S. Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiol. Aging 26 (2005) 1-7
16. Harhangi B.S., de Rijk M.C., van Duijn C.M., Van Broeckhoven C., Hofman A., and Breteler M.M. APOE and the risk of PD with or without dementia in a population-based study. Neurology 54 (2000) 1272-1276
17. Heikkinen T., Puolivali J., and Tanila H. Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice. Exp. Gerontol. 39 (2004) 1277-1283
18. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., Farrer L.A., and MIRAGE Study Group. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry 76 (2005) 103-105
19. Herz J., and Bock H.H. Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71 (2002) 405-434
20. Herz J., Kowal R.C., Ho Y.K., Brown M.S., and Goldstein J.L. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. J. Biol. Chem. 265 (1990) 21355-21362
21. Herz J., and Stricklan D.K. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108 (2001) 779-784
22. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G., and Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92 (1995) 9480-9484
23. Huang S.S., Leal S.M., Chen C.L., Liu I.H., and Huang J.S. Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells. FASEB J. 18 (2004) 1719-1721
24. Kolsch H., Ptok U., Mohamed I., Schmitz S., Rao M.L., Maier W., and Heun R. Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 121 (2003) 128-130
25. Kuopio A.M., Marttila R.J., Helenius H., and Rinne U.K. Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 52 (1999) 302-308
26. Ladu M.J., Reardon C., Van Eldik L., Fagan A.M., Bu G., Holtzman D., and Getz G.S. Lipoproteins in the central nervous system. Ann. N. Y. Acad. Sci. 903 (2000) 167-175
27. LeBlanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285 (2001) 1489-1499
28. Levin-Allerhand J., McEwen B.S., Lominska C.E., Lubahn D.B., Korach K.S., and Smith J.D. Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. J. Neurochem. 79 (2001) 796-803
29. Li Y., Cam J., and Bu G. Low-density lipoprotein receptor family. Mol. Neurobiol. 23 (2001) 53-67
30. Marder K., Tang M.X., Alfaro B., Mejia H., Cote L., Jacobs D., Stern Y., Sano M., and Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50 (1998) 1141-1143
31. Mayeux R., Marder K., Cote L.J., Denaro J., Hemenegildo N., Mejia H., Tang M.X., Lantigua R., Wilder D., and Gurland B. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am. J. Epidemiol. 142 (1995) 820-827
32. McAsey M.E., Cady C., Jackson L.M., Li M., Randall S., Nathan B.P., and Struble R.G. Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed. Exp. Neurol. 197 (2006) 197-205
33. Nathan B.P., Barsukova A.G., Shen F., McAsey M., and Struble R.G. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145 (2004) 3065-3073
34. Nathan B.P., Jiang Y., Wong G.K., Shen F., Brewer G.J., and Struble R.G. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 928 (2002) 96-105
35. Paganini-Hill A., and Henderson V. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140 (1994) 256-261
36. Pietrzik C.U., Yoon I.S., Jaeger S., Busse T., Weggen S., and Koo E.H. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J. Neurosci. 24 (2004) 4259-4265
37. Qiu Z., Hyman B.T., and Rebeck G.W. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. J. Biol. Chem. 279 (2004) 34948-34956
38. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., and Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
39. Saunders-Pullman R., Gordon-Elliott J., Parides M., Fahn S., Saunders H.R., and Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology 52 (1999) 1417-1421
40. Simpkins J.W., Yang S.H., Wen Y., and Singh M. Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol. Life Sci. 62 (2005) 271-280
41. Srivastava R.A., Bhasin N., and Srivastava N. Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem. Mol. Biol. Int. 38 (1996) 91-101
42. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., and Finch C.E. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J. Neurosci. 18 (1998) 3180-3185
43. Struble R.G., Nathan B.P., Cady C., Cheng X., and McAsey M. Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration. Exp. Gerontol. 42 (2007) 54-63
44. Struble R.G., Rosario E.R., Kircher M.L., Ludwig S.M., McAdamis P.J., Watabe K., McAsey M.E., Cady C., and Nathan B.P. Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol. Exp. Neurol. 183 (2003) 638-644
45. Takayama Y., Takahashi H., Mizumachi K., and Takezawa T. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J. Biol. Chem. 278 (2003) 22112-22118
46. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
47. Tang G., Xie H., Xu L., Hao Y., Lin D., and Ren D. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am. J. Med. Genet. 114 (2002) 446-449
48. Yaffe K., Haan M., Byers A., Tangen C., and Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54 (2000) 1949-1954
49. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., and Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129
50. Zareparsi S., Camicioli R., Sexton G., Bird T., Swanson P., Kaye J., Nutt J., and Payami H. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am. J. Med. Genet. 107 (2002) 156-161